RA Capital Management’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,971,231
| Closed | -$18.7M | – | 67 |
|
|
2023
Q2 | $18.7M | Hold |
2,971,231
| – | – | 0.35% | 45 |
|
|
2023
Q1 | $17.1M | Hold |
2,971,231
| – | – | 0.39% | 48 |
|
|
2022
Q4 | $30.5M | Buy |
2,971,231
+198,000
| +7% | +$2.03M | 0.62% | 40 |
|
|
2022
Q3 | $46.4M | Buy |
2,773,231
+586,595
| +27% | +$9.81M | 0.99% | 34 |
|
|
2022
Q2 | $30.6M | Hold |
2,186,636
| – | – | 0.82% | 36 |
|
|
2022
Q1 | $35.3M | Hold |
2,186,636
| – | – | 0.77% | 41 |
|
|
2021
Q4 | $46.8M | Hold |
2,186,636
| – | – | 0.83% | 35 |
|
|
2021
Q3 | $32.1M | Hold |
2,186,636
| – | – | 0.45% | 50 |
|
|
2021
Q2 | $43.5M | Hold |
2,186,636
| – | – | 0.7% | 47 |
|
|
2021
Q1 | $65.4M | Buy |
+2,186,636
| New | +$65.4M | 0.99% | 33 |
|